JPMorgan analysts suggest Bitcoin may gain more support compared to gold if investors reduce their defensive hedging around cryptocurrency ETFs. While gold ETFs have fully recovered from earlier outflows in 2026, Bitcoin ETFs have only recovered about half, with Bitcoin investors still buying significant downside protection. This cautious positioning could reverse if sentiment improves, potentially boosting Bitcoin's performance relative to gold. JPMorgan's outlook on Bitcoin has shifted cautiously through 2026 amid regulatory uncertainty and institutional positioning, but easing hedges could create a positive setup for Bitcoin.
The JPMorgan outlook on Bitcoin versus gold is presented here alongside Pluang's cryptocurrency market snapshot. For readers following crypto trends, as of Sep 18, 2026 03:45 WIB, 46 of 50 major cryptocurrencies rose while 3 fell. Notable moves include SXP down 46.27%, COTI up 35.88% with a 53% sell order activity, and UNI up 20.34% with a 63% buy order activity, reflecting varied investor sentiment and positioning.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
